發展CRISPR/Cas、微小核醣核酸、反義寡核苷酸或干擾核醣核酸及抗癌藥物之奈 ... under review (SCI; IF = 4.6; Rank = 24.9% in Biochemistry & Molecular Biology;.
確定! 回上一頁